From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

BREAKING: Versarien admits its UK taxpayer loan breaks the rules: Lucian Miers writes to Alok Sharma

By Tom Winnifrith, The Sheriff of AIM | Tuesday 11 August 2020


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


It appears that a second charge has been registered at Companes House by taxpayer-backed Innovate UK for its £5 million loan to Versarien (VRS). This means that if Versarien defaults, taxpayers may well not get all their cash back. That on its own seems a clear breach of Innovate UK rules and a reason why this loan should not be made. But there is worse. In its quite atrocious results today, Versarien itself gives a reason for why the loan application is illegal. Lucian Miers has written to Business Secretary Alok Sharma to flag this up.

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 04:22:55